CompletedNot applicableNCT01432626

Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG

Studying Tako-Tsubo cardiomyopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Pittsburgh
Principal Investigator
Prem Soman, MD
University of Pittsburgh Heart Vascular Institute
Intervention
I-123 radiolabeled metaiodobenzylguanidine cardiac imaging(drug)
Enrollment
10 target
Eligibility
18 years · All sexes
Timeline
20112015

Study locations (1)

Collaborators

GE Healthcare

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01432626 on ClinicalTrials.gov

Other trials for Tako-Tsubo cardiomyopathy

Additional recruiting or active studies for the same condition.

See all trials for Tako-Tsubo cardiomyopathy

← Back to all trials